Vivos (RDGL) Cash & Equivalents (2010 - 2025)
Vivos (RDGL) posted Cash & Equivalents of $1.6 million for Q4 2025, down 29.23% sequentially from $2.2 million in Q3 2025, and down 29.56% YoY from $2.2 million in Q4 2024.
Vivos (RDGL) Cash & Equivalents (2010 - 2025) Analysis & Trends
Vivos has reported Cash & Equivalents for 16 years, with the latest figure at $1.6 million in Q4 2025.
- Quarterly Cash & Equivalents fell 29.56% year-over-year to $1.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.6 million (down 29.56% YoY) and the FY2025 annual result came in at $1.6 million, down 29.56% from the prior year.
- Cash & Equivalents slipped to $1.6 million in Q4 2025 per RDGL's latest filing, from $2.2 million in the prior quarter.
- Over five years, Cash & Equivalents peaked at $3.3 million in Q1 2025 and troughed at $1.1 million in Q2 2022.
- A 5-year average of $1.8 million and a median of $1.7 million in 2022 frame the typical range for Cash & Equivalents.
- The sharpest annual moves came in 2021 and 2022: Cash & Equivalents jumped 13202.47% in 2021, then slumped 51.46% in 2022.
- Over 5 years, Cash & Equivalents stood at $1.6 million in 2021, then rose by 6.22% to $1.7 million in 2022, then dropped by 6.67% to $1.6 million in 2023, then jumped by 38.95% to $2.2 million in 2024, then dropped by 29.56% to $1.6 million in 2025.
- According to Business Quant data, Cash & Equivalents over the past three periods registered $1.6 million, $2.2 million, and $2.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | 5.10 Bn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 3.39 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 2.91 Bn |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | 1.11 Bn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 3.25 Bn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Vivos | 24.90 Mn | 23.34 Mn | -3,105.00 | 1.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.56 Mn |
| Sep 30, 2025 | 2.20 Mn |
| Jun 30, 2025 | 2.66 Mn |
| Mar 31, 2025 | 3.27 Mn |
| Dec 31, 2024 | 2.21 Mn |
| Sep 30, 2024 | 1.22 Mn |
| Jun 30, 2024 | 1.72 Mn |
| Mar 31, 2024 | 1.37 Mn |
| Dec 31, 2023 | 1.59 Mn |
| Sep 30, 2023 | 1.54 Mn |
| Jun 30, 2023 | 1.75 Mn |
| Mar 31, 2023 | 1.41 Mn |
| Dec 31, 2022 | 1.71 Mn |
| Sep 30, 2022 | 1.99 Mn |
| Jun 30, 2022 | 1.05 Mn |
| Mar 31, 2022 | 1.22 Mn |
| Dec 31, 2021 | 1.61 Mn |
| Sep 30, 2021 | 1.99 Mn |
| Jun 30, 2021 | 2.16 Mn |
| Mar 31, 2021 | 2.51 Mn |